$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Taxol formulation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/127
  • A61K-009/133
출원번호 US-0151215 (1993-11-12)
발명자 / 주소
  • Straubinger Robert M. (Amherst NY) Sharma Amarnath (Buffalo NY) Mayhew Eric (South Wales NY)
출원인 / 주소
  • The Research Foundation of State University of New York (Buffalo NY 02)
인용정보 피인용 횟수 : 97  인용 특허 : 0

초록

The present invention relates to a pharmaceutical composition for use in treatment of cancer patients. The composition includes at least one taxane present in a pharmaceutical effective amount and a mixture of one or more negatively charged phospholipids and one or more zwitterion (i.e. uncharged) p

대표청구항

A pharmaceutical composition for use in treatment of cancer comprising: at least one taxane present in said composition in a pharmaceutically effective amount of 1.5-8.0 mol % and a mixture of one or more negatively charged phospholipids and one or more zwitterion phospholipids in a respective ratio

이 특허를 인용한 특허 (97)

  1. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  2. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  3. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  4. Robert A. Holton ; Ki-Byung Chai KR, C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them.
  5. Holton, Robert A.; Chai, Ki-byung, C7 acyloxy metal alkoxides.
  6. Holton, Robert A., C7 ester substituted taxanes.
  7. Holton,Robert A., C7 ester substituted taxanes.
  8. Holton,Robert A.; Kim,Hyeong Baik, C7 lactyloxy-substituted taxanes.
  9. McDonald,Donald M.; McLean,John W.; Thurston,O. Gavin, Cationic liposome delivery of taxanes to angiogenic blood vessels.
  10. McDonald,Donald M.; McLean,John W.; Thurston,O. Gavin, Cationic liposome delivery of taxanes to angiogenic blood vessels.
  11. Gao,Ping; Morozowich,Walter, Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability.
  12. Hunter, William L.; Machan, Lindsay S., Compositions and methods for treating or preventing diseases of body passageways.
  13. Kudirka, Romas Alvydas; Albers, Aaron Edward; Rabuka, David, Compounds and methods for producing a conjugate.
  14. Shanley,John F.; Parker,Theodore L., Drug delivery device and method for bi-directional drug delivery.
  15. Arslanian, Robert L.; Carney, John R.; Metcalf, Brian, Epothilone compounds and methods for making and using the same.
  16. Ashley, Gary; Arslanian, Robert L.; Carney, John; Metcalf, Brian; Tang, Li, Epothilone derivatives and methods for making and using the same.
  17. Ashley,Gary; Carney,John R.; Metcalf,Brian, Epothilone derivatives and methods for making and using the same.
  18. Shanley, John F., Expandable medical device delivery system and method.
  19. Shanley, John F., Expandable medical device for delivery of beneficial agent.
  20. Shanley, John F., Expandable medical device for delivery of beneficial agent.
  21. Shanley, John F., Expandable medical device for delivery of beneficial agent.
  22. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
  23. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
  24. Shanley,John F., Expandable medical device for delivery of beneficial agent.
  25. Shanley,John F.; Eigler,Neal L.; Park,Kinam; Edelman,Elazer R., Expandable medical device for delivery of beneficial agent.
  26. Shanley, John F., Expandable medical device with S-shaped bridging elements.
  27. Shanley, John F., Expandable medical device with beneficial agent concentration gradient.
  28. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
  29. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
  30. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
  31. Shanley, John F., Expandable medical device with ductile hinges.
  32. Shanley, John F., Expandable medical device with ductile hinges.
  33. Shanley, John F., Expandable medical device with ductile hinges.
  34. Shanley, John F.; Eigler, Neal L.; Edelman, Elazer R., Expandable medical device with improved spatial distribution.
  35. Shanley, John F., Expandable medical device with tapered hinge.
  36. Desai, Neil P.; Soon-Shiong, Patrick, Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof.
  37. Ahmad, Moghis U.; Ali, Shoukath M.; Ahmad, Ateeq; Sheikh, Saifuddin; Ahmad, Imran, Guggulphospholipid methods and compositions.
  38. Blatt, Lawrence M.; Seiwert, Scott D.; Hong, Jin, Hyperglycosylated polypeptide variants and methods of use.
  39. Shanley, John F.; Parker, Theodore L.; Park, Kinam, Implantable medical device with beneficial agent concentration gradient.
  40. Shanley,John F.; Parker,Theodore L., Implantable medical device with drug filled holes.
  41. Tardi, Paul; Webb, Murray; Mayer, Lawrence D.; Ickenstein, Ludger M., Lipid carrier compositions with enhanced blood stability.
  42. Kan,Pei; Wang,Ae June; Chen,Won Ko; Tsao,Chih Wan, Liposome for incorporating large amounts of hydrophobic substances.
  43. Needham David ; Sarpal Ranjit S., Liposomes containing active agents.
  44. Needham David, Liposomes containing active agents aggregated with lipid surfactants.
  45. Dattagupta Nanibhushan ; Das Aditya Ranjan ; Sridhar C. Nagaraja ; Patel Jasmin R., Liposomes containing cationic lipids and vitamin D.
  46. Chen, Andrew Xian, Low oil emulsion compositions for delivering taxoids and other insoluble drugs.
  47. Diaz, Stephen Hunter; Park, Kinam, Method and apparatus for loading a beneficial agent into an expandable medical device.
  48. Diaz, Stephen Hunter; Park, Kinam, Method and apparatus for loading a beneficial agent into an expandable medical device.
  49. Shanley, John F.; Diaz, Stephen Hunter, Method and apparatus for loading a beneficial agent into an expandable medical device.
  50. Chaubal, Mahesh; Werling, Jane; Rabinow, Barrett, Method for preparing submicron particles of antineoplastic agents.
  51. Dattagupta Nanibhushan ; Das Aditya Ranjan ; Sridhar C. Nagaraja ; Patel Jasmin R., Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D.
  52. Sridhar C. Nagaraja ; Patel Jasmin R. ; Dattagupta Nanibhushan ; Das Aditya Ranjan, Method for the intracellular delivery of biomolecules using thiocationic lipids.
  53. Johnson, Jr., Robert; Zhou, Yiqing; Müller, Thomas, Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics.
  54. Mescheder, Axel; Karrasch, Matthias, Method of administering a cationic liposomal preparation.
  55. Rahman,Aquilar, Method of administering liposomal encapsulated taxane.
  56. Flashner-Barak, Moshe, Method of administration of paclitaxel-plasma protein formulation.
  57. Mundus, Carsten; Welz, Christian; Schramel, Oliver; Haas, Heinrich; Fichert, Thomas; Schulze, Brita; Peymann, Toralf; Michaelis, Uwe; Teifel, Michael; Gruber, Friedrich; Winter, Gerhard, Method of producing a cationic liposomal preparation comprising a lipophilic compound.
  58. Mundus, Carsten; Welz, Christian; Schramel, Oliver; Haas, Heinrich; Fichert, Thomas; Schulze, Brita; Peymann, Toralf; Michaelis, Uwe; Teifel, Michael; Gruber, Friedrich; Winter, Gerhard, Method of producing a cationic liposomal preparation comprising a lipophilic compound.
  59. Mundus, Carsten; Welz, Christian; Schramel, Oliver; Haas, Heinrich; Fichert, Thomas; Schulze, Brita; Peymann, Toralf; Michaelis, Uwe; Teifel, Michael; Gruber, Friedrich; Winter, Gerhard, Method of producing a cationic liposomal preparation comprising a lipophilic compound.
  60. Mundus, Carsten; Welz, Christian; Schramel, Oliver; Haas, Heinrich; Fichert, Thomas; Schulze, Brita; Peymann, Toralf; Michaelis, Uwe; Teifel, Michael; Gruber, Friedrich; Winter, Gerhard, Method of producing a cationic liposomal preparation comprising a lipophilic compound.
  61. Johnson, Jr., Robert G.; Hannah, Alison L.; Cropp, Gillian F.; Zhou, Yiqing; Sherrill, J. Michael, Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either.
  62. Javeri, Indu; Nellaiappan, Kaliappanadar, Methods for the preparation of liposomes.
  63. Javeri, Indu; Nellaiappan, Kaliappanadar; Dixit, Bharat, Methods for the preparation of liposomes.
  64. Javeri, Indu; Nellaiappan, Kaliappanadar, Methods for the preparation of liposomes comprising docetaxel.
  65. Javeri, Indu; Nellaiappan, Kaliappanadar, Methods for the preparation of liposomes comprising drugs.
  66. Augustine, John G.; Nellaiappan, Kaliappanadar; Isaacs, Benjamin S.; Isaacs, Indu J., Methods of enhancing solubility of agents.
  67. Augustine,John G.; Nellaiappan,Kaliappanadar; Isaacs,Benjamin S.; Isaacs,Indu J., Methods of enhancing solubility of compounds.
  68. Yang, Wenjin; Chen, Che-Hong; Mochly-Rosen, Daria, Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof.
  69. Yang, Wenjin; Chen, Che-Hong; Mochly-Rosen, Daria, Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof.
  70. Chen, Che-Hong; Mochly-Rosen, Daria; Yang, Wenjin, Modulators of aldehyde dehydrogenase activity and methods of use thereof.
  71. Mochly-Rosen, Daria; Chen, Che-Hong; Yang, Wenjin, Modulators of aldehyde dehydrogenase and methods of use thereof.
  72. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  73. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  74. Nabeta, Kiichiro, Non-aqueous taxane nanodispersion formulations and methods of using the same.
  75. I-Ming Chu TW; Tzy-Rong Wang TW, Oil-in-water emulsion for encapsulating paclitaxel.
  76. Brown, Douglas L., Parenteral formulations comprising sugar-based esters and ethers.
  77. Walter Perkins ; Xingong Li ; Donald Hirsh ; Eric Mayhew ; Imran Ahmad ; Shaukat Ali ; Andrew Janoff, Particulate formulations.
  78. Augustine, John G.; Nellaiappan, Kaliappanadar; Isaacs, Benjamin S.; Isaacs, Indu J., Pharmaceutical compositions of hydrophobic compounds.
  79. Nikolayev Aleksandr ; Sayeed Fakrul ; Iyer Rupa ; Garber Mitchell ; Butterhof Robert C. ; Hoyer Todd M. ; Samson Marvin, Polyethoxylated castor oil, process of making the same and formulations thereof.
  80. Scott, Neal; Segal, Jerome; Shih, Lih Bin; Burkoth, Terry L., Polymer coated device for electrically medicated drug delivery.
  81. Keller, Brian Charles; Lasic, Danilo; Lasic, legal representative, Alenka, Self forming, thermodynamically stable liposomes and their applications.
  82. Keller, Brian Charles; Lasic, legal representative, Alenka, Self forming, thermodynamically stable liposomes and their applications.
  83. Keller,Brian Charles; Lasic, legal representative,Alenka; Lasic, deceased,Dan D., Self forming, thermodynamically stable liposomes and their applications.
  84. Robert M. Straubinger ; Sathyamangalam V. Balasubramanian, Stabilization of taxane-containing dispersed systems.
  85. Zhang, Jia-Ai; Ugwu, Sydney; Ma, Lan; Anyarambhatla, Gopal; Ahmad, Imran, Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs.
  86. Kiichiro, Nabeta, Taxane pro-emulsion formulations and methods making and using the same.
  87. Rortais, Patricia; Gachon, Carine, Taxoid-based compositions.
  88. Bouchard,Herv챕; Bourzat,Jean Dominique; Commercon,Alain, Taxoids, their preparation and pharmaceutical composition containing them.
  89. Shanley, John F.; Parker, Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
  90. Shanley,John F.; Parker,Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
  91. Redelmeier,Thomas; Kauvar,Lawrence M.; Lum,Robert T.; Lyttle,Matthew H.; Macsata,Robert W.; Schow,Steven R.; Villar,Hugo O.; Kozlowski,Michael R., Therapeutic compositions containing glutathione analogs.
  92. Kliche, Kay-Oliver; Mescheder, Axel; Piccart, Martine, Treatment of breast cancer.
  93. Kliche, Kay-Oliver; Mescheder, Axel; Piccart, Martine, Treatment of triple receptor negative breast cancer.
  94. Kliche, Kay-Oliver; Mescheder, Axel; Piccart, Martine, Treatment of triple receptor negative breast cancer.
  95. Lih, Chih Jian; Cohen, Stanley N., Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby.
  96. Ozes,Osman N.; Blatt,Lawrence M.; Seiwert,Scott D., Use of pirfenidone in therapeutic regimens.
  97. Chen, Andrew Xian, Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로